Stock Events

Stock Events

Cardiol Therapeutics (CT9.STU) Q2 2026 Earnings

11MayConfirmed

Q2 2026

-0.06

-0.06

-0.06

-0.05

Details

Expected EPS

-0.054932030172000004

Actual EPS

-0.06103558908

Surprise EPS

-0.01

Surprise Percent

+11.11%

Description

Cardiol Therapeutics (CT9.STU) has reported earnings of -0.06103558908 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.